Company Profile

TRANSCENTA-B

6628 Biotechnology
Description

Transcenta Holding Limited, a clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People's Republic of China and the United States. The company develops MSB2311, a humanized PD-L1 monoclonal antibody (mAb) candidate for TMB-H solid tumors; TST001, a humanized claudin 18.2 mAb candidate for solid tumors, such as gastric and gastroesophageal cancer; TST005, a PD-L1/TGF-ß bi-functional protein candidate for solid tumors; TST002 (Blosozumab), a humanized sclerostin mAb candidate for osteoporosis; and TST004, a humanized mannan-binding lectin serine protease 2 (MASP 2) mAb candidate for IgA kidney diseases. It also develops TST010, an antibody candidate targeting regulatory T cells to enhance T cell mediated tumor killing; TST003, a regulatory protein expressed by stromal cells and tumor cells, including colon, prostate, gastric, lung, esophageal, pancreatic, and breast cancers; TST006, a bi-specific claudin 18.2/PD-L1 antibody for solid tumors; TST008, a bi-functional antibody for MASP-2 and BAFF for autoimmune diseases; MSB0254, a humanized VEGFR-2 mAb candidate for solid tumors; MSB2311, A humanized PD-L1 mAb candidate for solid tumors; TST012 and TST013, an ADC candidate targeting biomarker expressing gastric cancer and other solid tumors; and TST801, a bifunctional fusion protein for autoimmune diseases. The company has a partnership and collaboration agreements with Bristol Myers Squibb and Eli Lilly & Company; research collaboration with Alebund Pharmaceuticals, Dana Farber Cancer Institute, and John Hopkins University; and technology collaboration with Merck KGaA. The company was formerly known as MabSpace International Limited and changed its name to Transcenta Holding Limited in June 2019. Transcenta Holding Limited was incorporated in 2010 and is headquartered in Suzhou, the People's Republic of China.

Reports

This company has 4 ESG reports available.

ESG Performance Overview

Select a KPI indicator to view performance trend

KPI Indicators

A1.1 Emission Types and Data
21 Data Points
Indicator Data Points Actions
SOₓ Emissions 6
NOₓ Emissions 6
NOₓ Emission Intensity (By Revenue) 1
SOₓ Emission Intensity (By Revenue) 1
PM Emission Intensity (By Revenue) 1
Airborne Particulate Matter (PM) Emissions 6
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
36 Data Points
Indicator Data Points Actions
Total GHG Emissions Intensity (By Revenue) 5
Scope 1 GHG Emissions Intensity (By Revenue) 5
Scope 2 GHG Emissions Intensity (By Revenue) 5
Total GHG Emissions 7
Direct GHG Emissions (Scope 1) 7
Indirect Energy Emissions (Scope 2) 7
A1.3 Hazardous Waste
14 Data Points
Indicator Data Points Actions
Total Hazardous Waste Intensity (By Revenue) 7
Total Hazardous Waste 7
A1.4 Non-Hazardous Waste
16 Data Points
Indicator Data Points Actions
Non-Hazardous Waste Disposed 5
Paper Waste 1
Non-Hazardous Waste (Office Waste) 2
Total Non-Hazardous Waste Intensity (By Revenue) 8

A2.1 Energy Consumption
64 Data Points
Indicator Data Points Actions
Energy Consumption Intensity (By Revenue) 7
Direct Energy Intensity (By Revenue) 6
Indirect Energy Intensity (By Revenue) 6
Comprehensive Energy Consumption Intensity (By Revenue) 4
Total Energy Consumption 4
Total Direct Energy Consumption 6
Gasoline Consumption 6
Diesel Fuel Consumption 6
Total Indirect Energy Consumption 6
Purchased Electricity 7
Purchased Steam 6
A2.2 Water Consumption
22 Data Points
Indicator Data Points Actions
Total Water Withdrawal 1
Total Wastewater Discharge 6
Water Consumption 7
Water Consumption Intensity (By Revenue) 7
Wastewater Discharge Intensity 1
A2.3 Energy Use Efficiency Targets
1 Data Points
Indicator Data Points Actions
Target Energy Consumption Reduction Percentage by 2030 Compared to 2021 1
A2.5 Total Packaging Material Used
14 Data Points
Indicator Data Points Actions
Packaging Materials Consumed 7
Packaging Material Intensity (By Revenue) 6
Packaging Material Intensity (By Product Weight) 1

B1.1 Amount and Distribution of Workforce
126 Data Points
Indicator Data Points Actions
Number of Total Employees 7
Number of Male Employees 7
Number of Female Employees 7
Percentage of Male Employees 7
Percentage of Female Employees 7
Number of Full-time Employees 7
Number of Part-time Employees 7
Percentage of Full-time Employees 7
Percentage of Part-time Employees 7
Number of Employees Aged Below 30 7
Number of Employees Aged 30-50 7
Number of Employees Aged Above 50 7
Percentage of Employees Aged Below 30 4
Percentage of Employees Aged 30-50 4
Percentage of Employees Aged Above 50 4
Number of Employees in Hong Kong 1
Number of Employees in Mainland China 7
Number of Employees in Overseas 4
Number of Employees in United States 3
Percentage of Employees in Hong Kong 1
Percentage of Employees in Mainland China 4
Percentage of Employees in Overseas 2
Percentage of Employees in United States 2
Number of Senior Management Employees 1
Number of Middle Management Employees 1
Number of General Employees 1
Percentage of Senior Management Employees 1
Percentage of Middle Management Employees 1
Percentage of General Employees 1
B1.2 Employee Turnover Rate
53 Data Points
Indicator Data Points Actions
Turnover Rate of Female Employees 7
Turnover Rate of Male Employees 7
Turnover Rate of Employees Aged Below 30 7
Turnover Rate of Employees Aged 30-50 7
Turnover Rate of Employees Aged Above 50 7
Turnover Rate of Employees in Hong Kong 1
Turnover Rate of Employees in Mainland China 5
Turnover Rate of Total Employees 7
Turnover Rate of Employees in Overseas 4
Turnover Rate of Employees in United States 1

B2.1 Number and Rate of Work-related Fatalities
12 Data Points
Indicator Data Points Actions
Number of Work-related Fatalities 6
Number of Fatalities as a Result of Work-related Injuries 4
Number of Fatalities of the Last 3 Years 2
B2.2 Lost Days Due to Work Injury
7 Data Points
Indicator Data Points Actions
Lost Days Due to Work-related Injuries 7
B2.3 Occupational Health and Safety Measures Adopted
3 Data Points
Indicator Data Points Actions
Health Check Coverage for Employees 1
Investment in Work Safety 2

B3.1 The Percentage of Employees Trained
22 Data Points
Indicator Data Points Actions
Percentage of Employees Trained 7
Percentage of Trained Male Employees 3
Percentage of Trained Female Employees 3
Percentage of Trained Senior Management 3
Percentage of Trained Middle Management 3
Percentage of Trained General Employees 3
B3.2 Average Training Hours Completed per Employee
29 Data Points
Indicator Data Points Actions
Total Training Hours 7
Average Training Hours per Employee 7
Average Training Hours (Male) 3
Average Training Hours (Female) 3
Average Training Hours (Senior Management) 3
Average Training Hours (Middle Management) 3
Average Training Hours (General Staff) 3

B5.1 Number of Suppliers by Geographical Region
29 Data Points
Indicator Data Points Actions
Number of Total Suppliers 7
Number of Suppliers in Overseas 3
Number of Suppliers in East China 3
Number of Suppliers in Central China 3
Number of Suppliers in North China 3
Number of Suppliers in South China 3
Number of Suppliers in Southwest China 1
Number of Suppliers in Northwest China 3
Number of Suppliers in Northeast China 3
B5.3 Supply Chain Risk Identification & Monitoring
2 Data Points
Indicator Data Points Actions
Number of Suppliers Participated in Sustainability Risk Assessment 2

B6.1 Products Recalled
1 Data Points
Indicator Data Points Actions
Number of Recalled Products for Safety and Health Reasons 1
B6.2 Products Complaints
1 Data Points
Indicator Data Points Actions
Number of Products and Service Related Complaints 1
B6.3 Protection on Intellectual Property Rights
3 Data Points
Indicator Data Points Actions
Number of Intellectual Property Rights Obtained by the Company 1
Number of Patents Held 1
Number of Trademark Registrations 1

B7.1 Confirmed Incidents of Corruption
1 Data Points
Indicator Data Points Actions
Number of Concluded Corruption Lawsuits 1
B7.2 Anti-corruption and Bribery Policies
1 Data Points
Indicator Data Points Actions
Percentage of Suppliers Accepting Anti-corruption Policies 1
B7.3 Anti-corruption Training
8 Data Points
Indicator Data Points Actions
Number of People Participated in Ethical Standards and Anti-corruption Training 1
Total Hours of Anti-corruption Training 1
Number of Directors and Management Attendance for Anti-corruption Training 1
Average Anti-corruption Training Hours for Directors and Management 1
Total Anti-corruption Training Hours for Directors and Management 1
Number of General Employees Attendance for Anti-corruption Training 1
Total Hours of Anti-corruption Training for Employees 1
Average Anti-corruption Training Hours for General Employees 1

B8.2 Resources Contributed to the Community
2 Data Points
Indicator Data Points Actions
Total Social Investment 1
Total Public Welfare Donations 1

General
1 Data Points
Indicator Data Points Actions
Total Non-Hazardous Waste 1

ESG Reports

Year Report Title Publication Date Raw KPIs Standard KPIs Processed Actions
2024 2024 Environmental, Social and Governance Report 2025-04-22 149 102 Yes
2023 2023 Environmental, Social and Governance Report 2024-04-18 268 194 Yes
2022 2022 Environmental, Social and Governance Report 2023-04-27 230 122 Yes
2021 2021 Environmental, Social and Governance Report 2022-05-26 119 71 Yes